Characteristics of Emotional Status and Autonomic Regulation in Patients with Ischemic Heart Disease and Sleep Disorders

被引:0
|
作者
Ibatov A.D. [1 ]
机构
[1] Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health, Moscow
关键词
anxiety; depression; ischemic heart disease; sleep disorders;
D O I
10.1007/s11055-021-01180-5
中图分类号
学科分类号
摘要
Objectives: To study the features of emotional status and autonomic regulation in patients with ischemic heart disease and sleep disorders. Materials and methods. A total of 244 patients with functional class II–IV effort angina aged 36–72 (mean 56.9 ± 0.5 years) were studied. Emotional status was evaluated on the Hospital Anxiety and Depression Scale (HADS), the Beck Scale, and the Spielberger Scale. Autonomic status was assessed in terms of heart rate variability using 5-min cardiointervalogram traces at rest, Ewing cardiovascular tests, and an autonomic disorders questionnaire. Patients were divided into two groups depending on the severity of sleep impairments. Results. A total of 62 patients in the study cohort (25.4%) had no significant sleep impairment (≥22 points on the sleep quality questionnaire; these patients constituted group 2); 113 patients (46.3%) had severe sleep impairments (≤18 points on the sleep quality questionnaire; these patients constituted group 1); 69 patients (28.3%) had minor sleep impairments (19–21 points on the sleep quality questionnaire). Levels of anxiety and depression on the HADS were 9.2 ± 0.4 and 7.7 ± 0.4 points in group 1, compared with 5.9 ± 0.4 and 3.9 ± 0.4 points in group 2 (p < 0.001). Clinically marked autonomic disorders were seen in 100% of patients in group 1 and 75.8% of those in group 2 (p < 0.001). Mean scores on the autonomic impairments questionnaire were 41.8 ± 1.2 in group 1 and 25.6 ± 1.6 in group 2 (p < 0.001). Conclusions. Patients with sleep disorders had higher levels of anxiety, depression, and autonomic impairments, as well as lesser heart rhythm variability, which are unfavorable prognostic signs. This requires improvements in therapeutic and rehabilitation measures in this category of patients. © 2021, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:1207 / 1210
页数:3
相关论文
共 50 条
  • [31] Heart rate increment as a marker of sleep fragmentation in sleep disorders patients
    Sforza, E.
    Pichot, V.
    Cervena, K.
    Karunajeewa, A.
    Barthelemy, J.
    Roche, F.
    JOURNAL OF SLEEP RESEARCH, 2006, 15 : 33 - 33
  • [32] Changes of heart geometry in patients with ischemic heart disease
    Pangonyte, Dalia
    Stalioraityte, Elena
    Kazlauskaite, Danute
    Ziuraitiene, Reda
    Stanioniene, Zita
    Kerpauskiene, Sonata
    MEDICINA-LITHUANIA, 2008, 44 (01): : 8 - 14
  • [33] Regulation of microRNA Expression in Sleep Disorders in Patients with Epilepsy
    Dziadkowiak, Edyta
    Chojdak-Lukasiewicz, Justyna
    Olejniczak, Piotr
    Paradowski, Boguslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [34] Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease
    Britareva, VV
    Afanasieva, OI
    Dobrovolsky, AB
    Titaeva, EV
    Karpov, YA
    Pokrovsky, SN
    KARDIOLOGIYA, 2002, 42 (05) : 4 - 8
  • [35] CLINICO-IMMUNOLOGICAL DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND METABOLIC SYNDROME: CORRECTION WITH NEBIVOLOL
    Teplyakov, A. T.
    Bolotskaya, L. A.
    Vdovina, T. V.
    Stepacheva, T. A.
    Kuznetsova, A. V.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (12) : 44 - 52
  • [36] Prognostic assessment of epidemiological characteristics of ischemic heart disease
    Shalnova, SA
    Deev, AD
    Shestov, DB
    Kapustina, AV
    Konstantinov, VV
    Zhukovsky, GS
    KARDIOLOGIYA, 1997, 37 (09) : 49 - 54
  • [37] CHARACTERISTICS OF ERYTHROCYTES AND HEMOGLOBIN IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS
    Gorokhova, S. G.
    Atamanova, M. A.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (10) : 16 - 21
  • [38] The effect of exercise therapy on depressive and anxious symptoms in patients with ischemic heart disease: A systematic review
    Verschueren, Suzanne
    Eskes, Anne M.
    Maaskant, Jolanda M.
    Roest, Annelieke M.
    Latour, Corine H. M.
    Reimer, Wilma Scholte Op
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2018, 105 : 80 - 91
  • [39] Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis
    Ostuzzi, Giovanni
    Turrini, Giulia
    Gastaldon, Chiara
    Papola, Davide
    Rayner, Lauren
    Caruso, Rosangela
    Grassi, Luigi
    Hotopf, Matthew
    Barbui, Corrado
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 65 - 75
  • [40] Hemorheological disorders and arteriolar resistance during ischemic heart disease
    Urdulashvili, T
    Momtselidze, N
    Mantskava, A
    Narsia, N
    Mchedlishvili, G
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2004, 30 (3-4) : 399 - 401